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Mutations in troponin, an important muscle protein complex, can result in car-
diomyopathy by interfering with the normal muscle activity of the heart. Tro-
ponin T (TnT) is the largest subunit of troponin and is involved in binding the
troponin complex to the thin filament. Investigation of two mutations associ-
ated with cardiomyopathy in TnT, I90M and R173Q, showed different physi-
ological characteristics. The TnT I90Mmutation was identified as the causative
agent of familial hypertrophic cardiomyopathy (FHC) in a large multi-genera-
tional Chinese family and at least two family members with this mutation died
of sudden cardiac death. Another mutation in TnT, R173Q, was identified as the
underlying cause of dilated cardiomyopathy (DCM). Patients with the TnT
R173Q mutation experienced prenatal onset DCM and supraventricular tachy-
cardia at a young age. Functional troponin complexes containing wild-type or
mutant TnT’s demonstrated similar maximal actomyosin ATPase activity. The
inhibitory ability of the troponin complexes containing the I90M mutation was
significantly reduced relative to wild-type TnT. Most RCM mutations investi-
gated to date showed a reduced ability to inhibit actomyosin ATPase activity
but the RCM mutation, R173Q, did not affect the inhibitory ability of troponin.
The mutations showed increased (I90M) and decreased (R173Q) calcium sen-
sitivity of actomyosin ATPase activity consistent with what has been observed
for most FHC and DCMmutations. The mutations reduced the rate of degrada-
tion of these proteins by calpain relative to wild-type TnT. Overall, these results
suggest that although calcium sensitivity may be an indicator of the type of car-
diomyopathy no clear trends in maximal or minimal ATPase activity exist that
can be used to characterize DCM and FHC mutations.
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A novel double deletion in cardiac troponin T (cTnT) of two highly conserved
amino acids (N100 and E101) was identified in the cardiac cDNA of a pediatric
transplant recipient. The patient previously presented with restrictive and hy-
pertrophic cardiomyopathy. Family work-up was negative, and she was found
to harbor a de novo mutation. Electron microscopy revealed the presence of
myofibrillar disarray and fibrosis. To further define this cTnT mutation as
a cause of the disease, functional studies were performed. Functional effects
of the single and double cTnT mutants (DN100, DE101 and DN100/DE101)
were analyzed in porcine skinned papillary muscle. Fibers were displaced
with exogenous cTnT mutants or WT, Ca2þ unregulated force was measured
and then reconstituted with binary cTnI.cTnC complex. The DN100 and
DE101 mutations showed opposing changes in the Ca2þ sensitivity of force de-
velopment compared to WT. The DN100 mutation increased this by 0.29 pCa
units and the DE101 mutation, in contrast, decreased it by 0.28 pCa units. In-
terestingly, the DN100/DE101 mutation shifted the Ca2þ sensitivity to the left
(þ 0.19 pCa units). This finding is compatible with the preserved systolic func-
tion in this patient. DE101 was the only mutation that decreased the maximal
force recovery compared to WT. In contrast, DN100 and DN100/DE101 did
not show significant changes in this parameter. Both DN100 and DN100/
DE101 exhibited decreased cooperativity of force development, suggesting al-
tered intra-filament protein-protein interactions. These data show that residue
N100 has a predominant effect over E101 and its absence is much more dele-
terious for cTnT function. In addition, the strength of the functional data vali-
dates this novel cTnT deletion mutant as the cause of this cardiomyopathy. Sup-
ported by NIH HL-42325(JDP), AHA 0825368E (JRP), AHA 09POST2300030
(MSP) and CIHR GMHD 79045 (GA).
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A paucity of information exists concerning the functional roles of the human
slow skeletal troponin T isoforms (HSSTnT isoforms) in different muscle
types. Three HSSTnT isoforms have been found in slow skeletal muscle:HSSTnT1 (þ Exons 5 and 12), HSSTnT2 (þ5, 12), HSSTnT3 (5, 12)
and HSSTnT4 (5,þ12, only found at the mRNA level). Soleus rabbit skinned
fibers were displaced with HSSTnT1, 2, 3 or 4 and reconstituted with human
SSTnI-C/STnC complex. The extent of Tn displacement was analyzed by mea-
suring the Ca2þ unregulated force (UF) at pCa 8.0 after SSTnT treatment. The
UF ranged from 63 to 73%. The Ca2þ sensitivity increased between SSTnT iso-
forms: isoform 1 (pCa50 ¼ 5.73) < isoform 2 (pCa50 ¼ 5.80) < isoform 3
(pCa50 ¼ 5.84). HSSTnT4 yielded a pCa50 ¼ 5.78. Using a reconstituted fast
skeletal muscle system, the actomyosin ATPase activity containing different
HSSTnT isoforms was determined. The HSSTnT isoforms did not alter ATPase
activation or inhibition in the presence or absence of Ca2þ. Potential interac-
tions between human cardiac troponin C (HcTnC), rabbit skeletal tropomyosin
(RsTm) and human cardiac troponin I (HcTnI) with SSTnT were mapped. Dot
blot analysis using HRP conjugated proteins revealed new interactions between
SSTnT peptides and HcTnC, RsTm and HcTnI. These results may help identify
the functional differences that occur between SSTnT isoforms due to their al-
ternative splicing. Supported by NIH HL-042325(JDP) and AR-050199 (JDP)
and AHA 0825368E (JRP).
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In vitro investigations into Hypertrophic Cardiomyopathy (HCM) and Restric-
tive Cardiomyopathy (RCM) show that mutations in cardiac Troponin T (cTnT)
produce a pathogenic state via increase in myofilament Ca2þ sensitivity,
whereas mutations in cTnT that cause Dilated Cardiomyopathy (DCM) de-
crease Ca2þ sensitivity and maximal force. Our aim was to determine whether
combinatory mutations of an HCM, RCM and a DCM in cTnT yield an inter-
mediate or dominant functional phenotype that could be correlated with the
clinical condition seen in patients. Standard laboratory methods were used
for cloning, expression and purification of the WT and mutants: DK210
(DCM), I79N (HCM), DE96 (RCM), DK210/I79N, DK210/DE96 and DE96/
I79N. Porcine papillary skinned fibers were displaced with cTnTWT or mutant
and reconstituted with HCTnI-TnC. The Ca2þ sensitivity of force development,
maximal force and basal force were evaluated. The extent of TnT displacement
was analyzed by measuring the unregulated tension at pCa 8.0 after cTnT treat-
ment and none of the mutants showed an inability to displace the native cTn
complex. Both double mutants (DK210/I79N and DK210/DE96) containing
the DCM mutant showed a rightward shift in the Ca2þ sensitivity with a de-
crease in maximal force. In addition, the DK210 mutation rescued the impaired
relaxation produced by the RCMmutation (DE96). From the skinned fiber data,
DK210 has a dominant effect over I79N and DE96 mutations in cTnT. Circular
dichroism measurements demonstrated that all three double mutants had lower
alpha helical content than WT. In contrast, single mutants I79N (significantly)
and DK210 (showed a tendency) to increase alpha helical content. These results
suggest that cTnT can exist in multiple conformations that may be responsible
for these distinct functional phenotypes. NIH HL-67415 and HL-42325 (JDP),
AHA 0825368E (JRP).
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Ca2þ desensitization of myofilaments is indicated as a primary mechanism for
the pathogenesis of familial dilated cardiomyopathy (DCM) associated with the
deletion of lysine 210 (DK210) in cardiac troponin T (cTnT). DK210 knock-in
mice closely recapitulate the clinical phenotypes documented in patients with
this mutation. Considerable evidence supports the proposition that phosphory-
lation of cardiac sarcomeric proteins is a key modulator of function and may
exacerbate the effect of the deletion. In this study we investigate the impact
of K210 deletion on phosphorylation propensity of sarcomeric proteins. Quan-
titative analysis of cardiac myofibrils isolated from DK210 hearts identified
a decrease in basal phosphorylation of cTnI (46%), cTnT (29%) and MyBP-
C (31%) compared with wild type controls. Interestingly, immunoblot analyses
with phospho-specific antibodies show augmented phosphorylation of cTnT-
Thr203 (28%) and decreased phosphorylation of cTnI-Ser23/24 (41%) in mutant
myocardium. In vitro kinase assays indicate that DK210 increases phosphory-
lation propensity of cTnT-Thr203 three fold without changing cTnI-Ser23/24
